Published in Arch Biochem Biophys on November 01, 1983
Aprotinin and cardiac surgery. BMJ (1991) 1.94
On the association of glycoprotein Ib and actin-binding protein in human platelets. J Cell Biol (1985) 1.80
Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Proc Natl Acad Sci U S A (1987) 1.73
Calmodulin-binding proteins as calpain substrates. Biochem J (1989) 1.58
Calpain inhibition by peptide epoxides. Biochem J (1985) 1.49
Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa. J Cell Biol (1993) 1.15
Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res (2009) 1.06
Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies. Biochem J (1987) 0.90
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol (1994) 5.76
Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med (1992) 4.39
Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev (1993) 3.96
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med (1994) 3.09
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun (1993) 2.56
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med (1994) 2.54
Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res (1996) 2.36
Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res (1995) 2.24
Interrelations of platelet aggregation and secretion. J Clin Invest (1977) 1.93
Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A (1988) 1.78
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest (1996) 1.76
Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75
False increase of cardiac troponin I with heterophilic antibodies. Clin Chem (1998) 1.63
Platelet secretion induced by divalent cation ionophores. Nature (1974) 1.60
Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem (1998) 1.60
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci (1992) 1.54
Equilibrium binding of thrombin to platelets. Biochemistry (1976) 1.48
Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol (1995) 1.39
Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels. Can J Anaesth (1989) 1.39
Inhibition of platelet secretion by an antagonist of intracellular calcium. Biochem Biophys Res Commun (1976) 1.37
Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol (1995) 1.35
Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol (1995) 1.30
Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry (1973) 1.29
Kinetics of the thrombin-induced release of calcium (II) by platelets. Biochemistry (1973) 1.27
Variability in transport rates of secretory glycoproteins through the endoplasmic reticulum and Golgi in human hepatoma cells. J Biol Chem (1985) 1.25
Protein disulfide isomerase activity is released by activated platelets. Blood (1992) 1.21
Characterization of protein disulphide isomerase released from activated platelets. Br J Haematol (1995) 1.16
Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril (1996) 1.16
Evidence that calcium regulates platelet function. Thromb Haemost (1978) 1.14
Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain. Exp Neurol (1976) 1.08
Platelet stimulation by thrombin and other proteases. Biochemistry (1975) 1.08
Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d. Biochem Biophys Res Commun (1989) 1.07
Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms. J Biol Chem (1986) 1.05
Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors. Science (1978) 1.05
Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am J Pathol (1996) 1.05
Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem (1980) 1.01
Trends in the pattern of blindness and major ocular diseases in Singapore and Asia. Ann Acad Med Singapore (1998) 1.01
Causes and management of Descemet's membrane detachment associated with cataract surgery--not always a benign problem. Ann Acad Med Singapore (2001) 0.99
Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun (1991) 0.98
Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. J Biol Chem (1979) 0.97
Stimulus-secretion coupling in platelets. Effects of drugs on secretion on adenosine 5'-triphosphate. Biochemistry (1975) 0.95
Thrombin-induced phosphoinositide hydrolysis in platelets. Receptor occupancy and desensitization. Biochem J (1987) 0.93
Reactivity of individual tyrosyl residues of horse heart ferricytochrome c toward iodination. Biochemistry (1970) 0.93
Characteristics of the synergistic actions of platelet agonists. Blood (1981) 0.91
The effects of lithium on platelet phosphoinositide metabolism. Biochem J (1986) 0.91
Letter to the editors-in-chief: Absence of a requirement for extracellular calcium for secretion from platelets. Thromb Res (1975) 0.90
Quantitative evaluation of the loss of human platelet dense bodies following stimulation by thrombin or A23187. J Physiol (1977) 0.89
Reassessment of the evidence for the role of secreted ADP in biphasic platelet aggregation. Mechanism of inhibition by creatine phosphate plus creatine phosphokinase. J Lab Clin Med (1980) 0.89
Free thiols of platelet thrombospondin. Evidence for disulfide isomerization. J Biol Chem (1990) 0.89
Thrombin adsorption to surfaces and prevention with polyethylene glycol 6,000. Thromb Res (1976) 0.88
A second form of actin: platelet microfilaments depolymerized by ATP and divalent cations. Arch Biochem Biophys (1975) 0.87
Thiol-disulfide isomerization in thrombospondin: effects of conformation and protein disulfide isomerase. Blood (1997) 0.87
In vivo effect of protease inhibitors in denervation atrophy. Exp Neurol (1979) 0.86
Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res (1996) 0.86
Anaemia--more than meets the eye. Singapore Med J (1998) 0.85
Ester and amide derivatives of E64c as inhibitors of platelet calpains. J Med Chem (1992) 0.85
Thiol-disulfide exchange by thrombospondin: evidence for a thiol and a disulfide bond protected by calcium. Arch Biochem Biophys (1986) 0.85
Relationship between myosin structure and muscle degeneration. Ann N Y Acad Sci (1979) 0.85
Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion. Nature (1977) 0.85
Swainsonine treatment accelerates intracellular transport and secretion of glycoproteins in human hepatoma cells. J Biol Chem (1985) 0.85
Proteolysis of myosin during platelet storage. J Clin Invest (1974) 0.84
Regulation of platelet phosphorylase. Biochim Biophys Acta (1975) 0.84
Effects of deoxyglucose on platelet metabolism. Biochim Biophys Acta (1971) 0.84
Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. J Urol (1995) 0.84
Levels of intermediates and cofactors of the glycolytic pathway and the citric acid cycle in rat platelets. Biochim Biophys Acta (1969) 0.83
Differential effects of 1-deoxynojirimycin on the intracellular transport of secretory glycoproteins of human hepatoma cells in culture. Mol Cell Biochem (1987) 0.83
Characterization of the thrombin-induced desensitization of platelet activation by thrombin. Thromb Res (1983) 0.83
Involvement of a tryptophan residue in the binding site of Escherichia coli galactose-binding protein. Biochemistry (1974) 0.83
Quantitative adsorption of platelet glycoprotein G (thrombin-sensitive protein, thrombospondin) to barium citrate. Biochem J (1984) 0.82
Rabbit muscle phosphorylase phosphatase. 2. Kinetic properties and behavior in glycogen particles. Biochemistry (1977) 0.82
Formation of a stable complex of thrombin and the secreted platelet protein glycoprotein G (thrombin-sensitive protein, thrombospondin) by thiol-disulfide exchange. Biochemistry (1984) 0.82
Control of energy metabolism in platelets. A comparison of aerobic and anaerobic metabolism in washed rat platelets. Biochim Biophys Acta (1970) 0.82
Correlation of thrombin-induced glycoprotein V hydrolysis and platelet activation. J Biol Chem (1983) 0.81
[Role of the vitreous body in diabetic retinopathy]. Klin Monbl Augenheilkd (1993) 0.81
Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol (2001) 0.81
Atrial natriuretic factor may mediate the renal effects of PEEP ventilation. Anesthesiology (1988) 0.80
Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. Arch Biochem Biophys (1988) 0.80
Diabetic retinopathy and serum lipids. Singapore Med J (2000) 0.80
Reactions of thrombin-serpin complexes with thrombospondin. Arch Biochem Biophys (1992) 0.80
Reduction of a disulfide bond of thrombospondin in the supernatant solution of activated platelets. Arch Biochem Biophys (1991) 0.79
Localization of a thrombin-sensitive calcium pool in platelets. J Histochem Cytochem (1975) 0.79
Mass screening for diabetic retinopathy--a report on diabetic retinal screening in primary care clinics in Singapore. Singapore Med J (1995) 0.79
Hypothetical models for the thrombin-platelet interaction. Ann N Y Acad Sci (1981) 0.79
The structure of hemopeptide 1-65 from cytochrome c. Arch Biochem Biophys (1972) 0.79
Glycated proteins in diabetes. Clin Lab Med (2001) 0.78
Inhibition by digitonin of bovine heart muscle DPNH-cytochrome c reductase and its specific reversal by the tocopherols. Biochem Biophys Res Commun (1964) 0.78
Binding of thrombin to human platelet plasma membranes. Biochim Biophys Acta (1978) 0.78
Diabetic retinopathy--results of a two year screening programme in two medical units in Singapore. Ann Acad Med Singapore (1990) 0.77
Control of energy metabolism in platelets. The effects of thrombin and cyanide on glycolysis. Biochim Biophys Acta (1972) 0.77
Stimulus-response coupling in the thrombin-platelet interaction. Ciba Found Symp (1975) 0.77
Effects of digitonin and tocopherol on bovine heart muscle reduced diphosphopyridine nucleotide- and succinate-cytochrome c reductase and cytochrome c oxidase. J Biol Chem (1966) 0.77
Structural location of the tyrosyl and tryptophanyl residues of tuna heart cytochrome c. Biochemistry (1970) 0.77
Citrate anticoagulation during in vivo simulation of slow hemofiltration. Blood Purif (1990) 0.75
Differential effect of Serratia protease on platelet surface glycoproteins Ib and V. Blood (1985) 0.75